We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Stephen J. Immelt

CEO
Washington, D.C.

Stephen J. Immelt

Steve Immelt is chief executive officer (CEO) of Hogan Lovells. He is responsible for developing and driving our vision as a "bold and distinctive law firm creating valuable solutions for clients."

Steve spends his time focused on achieving the firm's strategy and supporting partners in building their relationships with clients and each other around the world. He has introduced into Hogan Lovells a major global initiative known as "Project Redefine," which seeks to improve the way we do things for the benefit of our clients in a rapidly changing and evolving market.

He is also passionate about leadership behavior, taking the view that everyone at Hogan Lovells should be clear about what is expected of them, whether partners, associates, or members of the business services teams.

Before taking up the role of CEO in 2014, Steve was the global co-head of our Litigation and Arbitration practice and a long-standing member of our International Management Committee. He has decades of experience working across markets and cultures in these roles and in his client work.

A litigator by background, in the early stages of his career Steve was an Assistant U.S. Attorney for the District of Maryland prosecuting political corruption, fraud, tax evasion, and conspiracy charges.

He then joined the firm in 1989 and built up a very successful practice dealing with complicated litigation in the healthcare sector. Clients have included pharmaceutical companies, medical device companies, academic health centers and medical schools, clinical laboratories, and other providers of healthcare. Steve has particular experience in off-label and financial relationship cases as well as the Anti-Kickback Act, the Food, Drug, and Cosmetics Act, the Foreign Corrupt Practices Act, and the False Claims Act.

"The 'excellent' Stephen Immelt... is noted for his expertise in government investigations and complex enforcement cases."

Chambers USA 2013

Representative Experience

Development of a vision and strategy for business growth for Hogan Lovells, a US$1.8bn business with operations in more than 40 offices worldwide.

Introduction of a vision for Hogan Lovells accompanied by a set of leadership behaviors designed to help everyone in the firm understand their role.

Achieved deferred prosecution, civil settlement, and corporate integrity agreements for a major orthopedic device company under investigation.

Advised medical device companies on False Claims Act matters arising from reimbursement, FDCA promotional, and fraud and abuse theories.

Advised pharmaceutical/biologics companies on federal and state investigations of sales and marketing, Medicaid rebate, and FDCA promotional issues.

Defended universities, academic health centers, and hospitals on False Claims Act disputes involving claims of billing, research, and program fraud.

Numerous assignments relating to the development of international compliance plans for corporate and institutional entities.

Successfully advised an institutional pharmacy provider with respect to Medicare Part D and related issues.

Advised medical device companies in investigations of business activities in China.

Education and admissions

Education

  • J.D., cum laude, University of Maryland School of Law, 1977
  • B.A., cum laude, Yale University, 1974

Memberships

  • Member, American Health Lawyers Association
  • Member, Health Law Section, American Bar Association
  • Member, National Association of College and University Attorneys

Bar admissions and qualifications

  • District of Columbia
  • Maryland
  • New York

Court admissions

  • Maryland Court of Appeals
  • U.S. Court of Appeals, District of Columbia Circuit
  • U.S. Court of Appeals, Fourth Circuit
  • U.S. Court of Appeals, Second Circuit
  • U.S. District Court, District of Columbia

2016

Eminent Practitioner, District of Columbia, Healthcare

Chambers USA

2006-2015

Healthcare: Regulatory & Litigation

Chambers USA

2004-2015

Litigation: General Commercial

Chambers USA

2006-2014

Maryland Super Lawyers

2012-2013

Life Sciences Star

LMG Life Sciences

2008-2013

Criminal Defense: White Collar

The Best Lawyers in America

1995-2013

Bet-the-Company Litigation

The Best Lawyers in America

1995-2013

Commercial Litigation

The Best Lawyers in America

1995-2013

Business Litigation

The Best Lawyers in America

2008

The International Who's Who of Business Crime Lawyers

 

Life Sciences

PLC Which Lawyer

Latest thinking and upcoming events

View More
Loading data